Close Menu

At O'Reilly Radar, there's an interview with synthetic biologist Reshma Shetty, who's recently co-founded a company called Gingko BioWorks. The Q&A delves into what she's up to, how synthetic biology can do more good than harm, the potential for regulation, and how to get kids interested in a career in not just biotech but synthetic biology.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Two COVID-19 vaccine developers have released their trial protocols to build public trust, the New York Times reports.

A new analysis finds the rapid COVID-19 test from DnaNudge to be highly accurate, Reuters reports.

In Science this week: global citizens' assembly on genome-editing technologies proposed, epigenetic markers predict metformin response, and more.

According to the Verge, many US states are not including positive results from rapid COVID-19 testing in their case numbers.